Your browser doesn't support javascript.
loading
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease.
Salloway, Stephen; Chalkias, Spyros; Barkhof, Frederik; Burkett, Patrick; Barakos, Jerome; Purcell, Derk; Suhy, Joyce; Forrestal, Fiona; Tian, Ying; Umans, Kimberly; Wang, Guanfang; Singhal, Priya; Budd Haeberlein, Samantha; Smirnakis, Karen.
  • Salloway S; Warren Alpert Medical School, Brown University, Providence, Rhode Island.
  • Chalkias S; Biogen, Cambridge, Massachusetts.
  • Barkhof F; Institutes of Healthcare Engineering and Neurology, University College London, London, United Kingdom.
  • Burkett P; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.
  • Barakos J; Biogen, Cambridge, Massachusetts.
  • Purcell D; California Pacific Medical Center, San Francisco.
  • Suhy J; Bioclinica, Newark, California.
  • Forrestal F; California Pacific Medical Center, San Francisco.
  • Tian Y; Bioclinica, Newark, California.
  • Umans K; Bioclinica, Newark, California.
  • Wang G; Biogen, Cambridge, Massachusetts.
  • Singhal P; Biogen, Cambridge, Massachusetts.
  • Budd Haeberlein S; Biogen, Cambridge, Massachusetts.
  • Smirnakis K; Cytel Inc, Waltham, Massachusetts.
JAMA Neurol ; 79(1): 13-21, 2022 01 01.
Article en En | MEDLINE | ID: mdl-34807243

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Enfermedad de Alzheimer / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Enfermedad de Alzheimer / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article